Latest Regulatory News

Dateline Resources progresses its Colosseum Gold-REE Project with a Bankable Feasibility Study underway, US government mining rights confirmed, and fresh capital raised to fuel development.

Invert Graphite has lodged a prospectus to raise up to A$3.5 million through a share offer priced at A$0.03 each, while advancing its acquisition of a Tanzanian critical minerals project. The company reported no exploration activity this quarter and incurred operating losses, reflecting a transitional phase ahead of relisting.

Ovanti Limited has addressed ASX concerns over its relationship with BNPLPay, clarifying key personnel roles, ownership structures, and cryptocurrency exposure tied to its Licence Agreement.

Wingara AG Limited’s shares have been suspended from ASX trading following a transaction announcement that could alter its core activities. The suspension will last until the company meets key listing rule requirements.

Orpheus Uranium Limited has fortified its Australian uranium portfolio by acquiring the Pirie Basin Project and raising $1.25 million to fund upcoming exploration, positioning itself strongly in key uranium provinces.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Pantera Lithium has identified six high-priority drilling locations for its Smackover Lithium Brine Project, supported by promising Arkansas legislation offering fiscal and regulatory incentives that could reshape the project's economics.

Estrella Resources is set to commence the first-ever minerals drilling program in Timor-Leste, backed by strong manganese assay results and a recent $3.75 million capital raise. The company has secured key environmental approvals and community support, positioning itself at the forefront of exploration in this emerging jurisdiction.

Core Energy Minerals has expanded its uranium portfolio with key South Australian acquisitions and secured $3.7 million in funding, setting the stage for maiden drilling at the Cummins Project.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Strike Resources has made significant strides in advancing its Apurimac Iron Ore Project in Peru, engaging closely with government officials and infrastructure partners to secure critical logistics and permitting milestones. Meanwhile, its stake in Lithium Energy Limited sees progress amid asset sales and spin-out plans.

XTC Lithium Limited has signed a Letter of Intent with American Battery Materials to jointly develop its Carachi Lithium Project in Argentina, while divesting non-core assets to sharpen its focus on lithium exploration.